A trial to investigate the antiviral effect, safety, tolerability, and pharmacokinetics of orally administered investigational capsid inhibitor monotherapy in HIV-1 infected treatment naive results.
Enrollment
Open
Patient Commitment Duration
2
Number of visits in study
12
Patient Compensation
$89 for all visits except for 1 visit that pays $250
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A Phase 3 study investigating the efficacy, safety, and tolerability of ritlecitnib in participants with non-segmental vitiligo.
Enrollment
Open
Patient Commitment Duration
52 weeks
Number of visits in study
11
Patient Compensation
$101 per study visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
RSV Positive patients that have an underlying medication condition or are 65+ years
Facility/Clinic
Accellacare – 1907 Tradd Ct
Age
18 years and older
Gender
Male & Female
Description
A study to measure the safety and efficacy of oral treatment compared with placebo for those who test positive for RSV and are at risk of progression to severe illness.
Enrollment
Open
Patient Commitment Duration
35 days
Number of visits in study
8+
Patient Compensation
$100 per onsite visit with a 50% travel reimbursement and $25 meal reimbursement
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
